These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 37111598)
1. Platelet Activation by Antisense Oligonucleotides (ASOs) in the Göttingen Minipig, including an Evaluation of Glycoprotein VI (GPVI) and Platelet Factor 4 (PF4) Ontogeny. Valenzuela A; Ayuso M; Buyssens L; Bars C; Van Ginneken C; Tessier Y; Van Cruchten S Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111598 [TBL] [Abstract][Full Text] [Related]
2. Safety Testing of an Antisense Oligonucleotide Intended for Pediatric Indications in the Juvenile Göttingen Minipig, including an Evaluation of the Ontogeny of Key Nucleases. Valenzuela A; Tardiveau C; Ayuso M; Buyssens L; Bars C; Van Ginneken C; Fant P; Leconte I; Braendli-Baiocco A; Parrott N; Schmitt G; Tessier Y; Barrow P; Van Cruchten S Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575518 [TBL] [Abstract][Full Text] [Related]
3. Sequence-specific 2'-O-methoxyethyl antisense oligonucleotides activate human platelets through glycoprotein VI, triggering formation of platelet-leukocyte aggregates. Slingsby MHL; Vijey P; Tsai IT; Roweth H; Couldwell G; Wilkie AR; Gaus H; Goolsby JM; Okazaki R; Terkovich BE; Semple JW; Thon JN; Henry SP; Narayanan P; Italiano JE Haematologica; 2022 Feb; 107(2):519-531. PubMed ID: 33567808 [TBL] [Abstract][Full Text] [Related]
5. Hepatic Cytochrome P450 Abundance and Activity in the Developing and Adult Göttingen Minipig: Pivotal Data for PBPK Modeling. Buyssens L; De Clerck L; Schelstraete W; Dhaenens M; Deforce D; Ayuso M; Van Ginneken C; Van Cruchten S Front Pharmacol; 2021; 12():665644. PubMed ID: 33935788 [TBL] [Abstract][Full Text] [Related]
6. The mechanism of thrombocytopenia caused by cholesterol-conjugated antisense oligonucleotides. Harada K; Furukawa H; Kohara H; Nishimura K; Komori H; Okai Y; Arai Y; Yamamoto Y; Yamamoto K; Imanishi A; Shinozawa T Toxicol In Vitro; 2023 Jun; 89():105569. PubMed ID: 36801361 [TBL] [Abstract][Full Text] [Related]
7. Assessing extent of brain penetration in vivo (K Langthaler K; Jones CR; Brodin B; Bundgaard C Eur J Pharm Sci; 2023 Nov; 190():106554. PubMed ID: 37543065 [TBL] [Abstract][Full Text] [Related]
8. Plant-based Food Cyanidin-3-Glucoside Modulates Human Platelet Glycoprotein VI Signaling and Inhibits Platelet Activation and Thrombus Formation. Yao Y; Chen Y; Adili R; McKeown T; Chen P; Zhu G; Li D; Ling W; Ni H; Yang Y J Nutr; 2017 Oct; 147(10):1917-1925. PubMed ID: 28855423 [No Abstract] [Full Text] [Related]
9. Antisense oligonucleotides and nucleic acids generate hypersensitive platelets. Zaslavsky A; Adams M; Cao X; Yamaguchi A; Henderson J; Busch-Østergren P; Udager A; Pitchiaya S; Tourdot B; Kasputis T; Church SJ; Lee SK; Ohl S; Patel S; Morgan TM; Alva A; Wakefield TW; Reichert Z; Holinstat M; Palapattu GS Thromb Res; 2021 Apr; 200():64-71. PubMed ID: 33540294 [TBL] [Abstract][Full Text] [Related]
10. The Aachen Minipig: Phenotype, Genotype, Hematological and Biochemical Characterization, and Comparison to the Göttingen Minipig. Pawlowsky K; Ernst L; Steitz J; Stopinski T; Kögel B; Henger A; Kluge R; Tolba R Eur Surg Res; 2017; 58(5-6):193-203. PubMed ID: 28433992 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation. Schulz C; Leuschen NV; Fröhlich T; Lorenz M; Pfeiler S; Gleissner CA; Kremmer E; Kessler M; Khandoga AG; Engelmann B; Ley K; Massberg S; Arnold GJ Blood; 2010 May; 115(20):4102-10. PubMed ID: 20107233 [TBL] [Abstract][Full Text] [Related]
12. The Effects of 2'-O-Methoxyethyl Containing Antisense Oligonucleotides on Platelets in Human Clinical Trials. Crooke ST; Baker BF; Witztum JL; Kwoh TJ; Pham NC; Salgado N; McEvoy BW; Cheng W; Hughes SG; Bhanot S; Geary RS Nucleic Acid Ther; 2017 Jun; 27(3):121-129. PubMed ID: 28145801 [TBL] [Abstract][Full Text] [Related]
13. The collagen receptor glycoprotein VI promotes platelet-mediated aggregation of β-amyloid. Donner L; Toska LM; Krüger I; Gröniger S; Barroso R; Burleigh A; Mezzano D; Pfeiler S; Kelm M; Gerdes N; Watson SP; Sun Y; Elvers M Sci Signal; 2020 Aug; 13(643):. PubMed ID: 32753479 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Göttingen minipig skin for transdermal in vitro permeation studies. Qvist MH; Hoeck U; Kreilgaard B; Madsen F; Frokjaer S Eur J Pharm Sci; 2000 Jul; 11(1):59-68. PubMed ID: 10913754 [TBL] [Abstract][Full Text] [Related]
15. Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcgammaRIIa and induce GPVI ectodomain shedding. Al-Tamimi M; Mu FT; Arthur JF; Shen Y; Moroi M; Berndt MC; Andrews RK; Gardiner EE Platelets; 2009 Mar; 20(2):75-82. PubMed ID: 19235048 [TBL] [Abstract][Full Text] [Related]
16. Identification of P2Y12-dependent and -independent mechanisms of glycoprotein VI-mediated Rap1 activation in platelets. Larson MK; Chen H; Kahn ML; Taylor AM; Fabre JE; Mortensen RM; Conley PB; Parise LV Blood; 2003 Feb; 101(4):1409-15. PubMed ID: 12393417 [TBL] [Abstract][Full Text] [Related]
17. Snake venom metalloproteinases, crotarhagin and alborhagin, induce ectodomain shedding of the platelet collagen receptor, glycoprotein VI. Wijeyewickrema LC; Gardiner EE; Moroi M; Berndt MC; Andrews RK Thromb Haemost; 2007 Dec; 98(6):1285-90. PubMed ID: 18064326 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effect of eltrombopag therapy on the platelet collagen receptor glycoprotein VI (GPVI) expression and soluble GPVI levels in young patients with immune thrombocytopenia. Tantawy AAG; Elsherif NHK; Ebeid FS; El-Gamal RAE; Ismail EAR; Kenny MA; Morcos MBE J Thromb Thrombolysis; 2023 Feb; 55(2):243-251. PubMed ID: 36479670 [TBL] [Abstract][Full Text] [Related]